These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19198151)

  • 21. Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies.
    Carpo M; Pedotti R; Allaria S; Lolli F; Matà S; Cavaletti G; Protti A; Pomati S; Scarlato G; Nobile-Orazio E
    J Neurol Sci; 1999 Oct; 168(2):78-84. PubMed ID: 10526187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
    Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
    Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
    Komagamine T; Yuki N
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.
    Ho TW; Willison HJ; Nachamkin I; Li CY; Veitch J; Ung H; Wang GR; Liu RC; Cornblath DR; Asbury AK; Griffin JW; McKhann GM
    Ann Neurol; 1999 Feb; 45(2):168-73. PubMed ID: 9989618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study.
    Sekiguchi Y; Uncini A; Yuki N; Misawa S; Notturno F; Nasu S; Kanai K; Noto Y; Fujimaki Y; Shibuya K; Ohmori S; Sato Y; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):23-8. PubMed ID: 22010183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
    Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum.
    Fukami Y; Wong AH; Funakoshi K; Safri AY; Shahrizaila N; Yuki N
    Eur J Neurol; 2016 Feb; 23(2):320-6. PubMed ID: 26176883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.
    Caudie C; Quittard Pinon A; Taravel D; Sivadon-Tardy V; Orlikowski D; Rozenberg F; Sharshar T; Raphaël JC; Gaillard JL
    J Neurol; 2011 Nov; 258(11):1958-64. PubMed ID: 21516465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of Guillain-Barré syndrome.
    Hughes RA; Hadden RD; Gregson NA; Smith KJ
    J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
    Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
    Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients.
    Fan C; Jin H; Hao H; Gao F; Sun Y; Lu Y; Liu Y; Lv P; Cui W; Teng Y; Huang Y
    Muscle Nerve; 2017 Apr; 55(4):470-475. PubMed ID: 27464289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N
    J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
    Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
    J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Guillain-Barré and Fisher syndromes: update on the pathophysiological role of antiganglioside antibodies].
    Kaida K
    Rinsho Shinkeigaku; 2012; 52(11):914-6. PubMed ID: 23196466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism.
    Yuki N; Uncini A
    Muscle Nerve; 2014 May; 49(5):629-35. PubMed ID: 24477718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome.
    Yamagishi Y; Kuwahara M; Suzuki H; Sonoo M; Kuwabara S; Yokota T; Nomura K; Chiba A; Kaji R; Kanda T; Kaida KI; Mutoh T; Yamasaki R; Takashima H; Matsui M; Nishiyama K; Sobue G; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1339-1342. PubMed ID: 33041261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
    Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
    J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-ganglioside complex antibody profiles in a recurrent complicated case of GQ1b-seronegative miller fisher syndrome and Bickerstaff brainstem encephalitis: a case report.
    Ito H; Hatanaka Y; Fukami Y; Harada Y; Kobayashi R; Okada H; Uchibori A; Chiba A; Okuda S
    BMC Neurol; 2018 May; 18(1):72. PubMed ID: 29792178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.